The Tuskegee syphilis experiment. The secret sale of Henrietta Lacks cancer research cells. Jim Crow laws affecting African Americans’ ability to receive medical treatment. For weeks, it’s been hard to hear over the clamor of millions of Americans lining up for COVID-19 vaccines. But not everyone has been enthused — namely, large swaths of minority communities, which comprise the populations disproportionately impacted by the virus, but whose hesitance is largely fueled by the country’s racist medical past.
Tag: Vaccine Trials
George Washington University Public Health/Medical Experts Available for Media Interviews on COVID-19 Vaccine
On Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19 vaccine, paving the way for approval. Researchers at the George Washington University led one of the 100 clinical sites testing…
UAlbany Experts Available to Discuss COVID-19 Vaccine Rollout
ALBANY, N.Y. (Nov. 19, 2020) – The United States has now surpassed 11 million COVID-19 cases since February and many Americans are scrambling to figure out how to safely celebrate the upcoming holiday season. But, promising vaccine news could signal…
UCLA to lead statewide coalition to address COVID-19’s impact on communities at risk
A coalition of 11 academic institutions and their community partners across California has received a $4.1 million grant from the NIH for a statewide community-engaged approach to addressing COVID-19 among populations that have been disproportionately affected by the pandemic.
Rutgers Experts Explore Questions, Concerns Over COVID-19 Vaccine Trials
As researchers race to develop a COVID-19 vaccine, a Rutgers infectious disease expert and a Rutgers bioethicist discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials and what a successful vaccine may mean.
Dengue new vaccine performs well in large trial, but safety remains key concern
News wise on Dengue related news. An experimental dengue vaccine has shown promising early results in a large, multicountry trial, but critical questions remain about its effectiveness and safety. Still unclear, for example, is whether the vaccine—which had an efficacy…